1162P Prolonged exposure to proton pump inhibitors (PPI) at the time of initiation of immune checkpoint blockade (ICB) mediates better clinical outcomes in patients with metastatic melanoma

  • Shohdy K
  • Hatahet Y
  • Gillham T
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Shohdy, K. S., Hatahet, Y., Gillham, T., Yacoub, E. T. T., Gupta, A., Gomes, F., … Cook, N. (2023). 1162P Prolonged exposure to proton pump inhibitors (PPI) at the time of initiation of immune checkpoint blockade (ICB) mediates better clinical outcomes in patients with metastatic melanoma. Annals of Oncology, 34, S693. https://doi.org/10.1016/j.annonc.2023.09.2978

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free